BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 22098699)

  • 1. Primary care physicians' perspectives towards managing rheumatoid arthritis: room for improvement.
    Garneau KL; Iversen MD; Tsao H; Solomon DH
    Arthritis Res Ther; 2011; 13(6):R189. PubMed ID: 22098699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Practical progress in realisation of early diagnosis and treatment of patients with suspected rheumatoid arthritis: results from two matched questionnaires within three years.
    Aletaha D; Eberl G; Nell VP; Machold KP; Smolen JS
    Ann Rheum Dis; 2002 Jul; 61(7):630-4. PubMed ID: 12079906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of the initiation of disease-modifying antirheumatic drugs in incident rheumatoid arthritis: a German perspective based on nationwide ambulatory drug prescription data.
    Steffen A; Holstiege J; Klimke K; Akmatov MK; Bätzing J
    Rheumatol Int; 2018 Nov; 38(11):2111-2120. PubMed ID: 30306254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient and rheumatologist perspectives on tapering DMARDs in rheumatoid arthritis: a qualitative study.
    Hazlewood GS; Loyola-Sanchez A; Bykerk V; Hull PM; Marshall D; Pham T; Barber CEH; Barnabe C; Sirois A; Pope J; Schieir O; Richards D; Proulx L; Bartlett SJ
    Rheumatology (Oxford); 2022 Feb; 61(2):606-616. PubMed ID: 33878168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationships between driving distance, rheumatoid arthritis diagnosis, and disease-modifying antirheumatic drug receipt.
    Polinski JM; Brookhart MA; Ayanian JZ; Katz JN; Kim SC; Lii J; Tonner C; Yelin E; Solomon DH
    Arthritis Care Res (Hoboken); 2014 Nov; 66(11):1634-43. PubMed ID: 24664991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do primary care physicians have a place in the management of rheumatoid arthritis?
    Rat AC; Henegariu V; Boissier MC
    Joint Bone Spine; 2004 May; 71(3):190-7. PubMed ID: 15182789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Patient, Prescriber, and Region With the Initiation of First Prescription of Biologic Disease-Modifying Antirheumatic Drug Among Older Patients With Rheumatoid Arthritis and Identical Health Insurance Coverage.
    Tatangelo M; Tomlinson G; Paterson JM; Ahluwalia V; Kopp A; Gomes T; Bansback N; Bombardier C
    JAMA Netw Open; 2019 Dec; 2(12):e1917053. PubMed ID: 31808927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of rheumatoid arthritis in the Medicare Current Beneficiary Survey.
    Solomon DH; Yelin E; Katz JN; Lu B; Shaykevich T; Ayanian JZ
    Arthritis Res Ther; 2013 Mar; 15(2):R43. PubMed ID: 23506671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of tumor necrosis factor inhibitors in rheumatoid arthritis: a national survey of practicing United States rheumatologists.
    Kamal KM; Madhavan SS; Hornsby JA; Miller LA; Kavookjian J; Scott V
    Joint Bone Spine; 2006 Dec; 73(6):718-24. PubMed ID: 16997599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time to consultation and disease-modifying antirheumatic drug treatment of patients with rheumatoid arthritis--northern Alberta perspective.
    Nanji JA; Choi M; Ferrari R; Lyddell C; Russell AS
    J Rheumatol; 2012 Apr; 39(4):707-11. PubMed ID: 22337235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prescribing practices in a US cohort of rheumatoid arthritis patients before and after publication of the American College of Rheumatology treatment recommendations.
    Harrold LR; Harrington JT; Curtis JR; Furst DE; Bentley MJ; Shan Y; Reed G; Kremer J; Greenberg JD
    Arthritis Rheum; 2012 Mar; 64(3):630-8. PubMed ID: 21953645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors associated with initial or subsequent choice of biologic disease-modifying antirheumatic drugs for treatment of rheumatoid arthritis.
    Jin Y; Desai RJ; Liu J; Choi NK; Kim SC
    Arthritis Res Ther; 2017 Jul; 19(1):159. PubMed ID: 28679392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of disease-modifying antirheumatic drugs in the treatment of rheumatoid arthritis. A survey of Alabama rheumatologists.
    Baum SK; Tracy IC; Henderson EH; Alarcón GS
    Arthritis Care Res; 1991 Mar; 4(1):48-51. PubMed ID: 11188587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DMARD non-use in low-income, elderly rheumatoid arthritis patients: results of 86 structured interviews.
    Brown EM; Garneau KL; Tsao H; Solomon DH
    Arthritis Res Ther; 2014 Jan; 16(1):R30. PubMed ID: 24472640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifying factors associated with concordance with the American College of Rheumatology rheumatoid arthritis treatment recommendations.
    Harrold LR; Reed GW; Kremer JM; Curtis JR; Solomon DH; Hochberg MC; Kavanaugh A; Saunders KC; Shan Y; Spruill TM; Pappas DA; Greenberg JD
    Arthritis Res Ther; 2016 Apr; 18():94. PubMed ID: 27118040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rheumatoid arthritis patients and rheumatologists approach the decision to escalate care differently: results of a maximum difference scaling experiment.
    van Hulst LT; Kievit W; van Bommel R; van Riel PL; Fraenkel L
    Arthritis Care Res (Hoboken); 2011 Oct; 63(10):1407-14. PubMed ID: 21748861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Population-Based Approach to Reporting System-Level Performance Measures for Rheumatoid Arthritis Care.
    Barber CEH; Marshall DA; Szefer E; Barnabe C; Shiff NJ; Bykerk V; Homik J; Thorne JC; Ahluwalia V; Benseler S; Mosher D; Twilt M; Lacaille D
    Arthritis Care Res (Hoboken); 2021 May; 73(5):640-648. PubMed ID: 32144843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors influencing clinician prescribing of disease-modifying anti-rheumatic drugs for inflammatory arthritis: A systematic review and thematic synthesis of qualitative studies.
    Lalor AF; Brooker JE; Rozbroj T; Whittle SL; Hill CL; Rowett D; Buchbinder R; O'Connor DA
    Semin Arthritis Rheum; 2022 Aug; 55():151988. PubMed ID: 35286905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of use of specialty services on disease-modifying antirheumatic drug use in the treatment of rheumatoid arthritis in an insured elderly population.
    Shipton D; Glazier RH; Guan J; Badley EM
    Med Care; 2004 Sep; 42(9):907-13. PubMed ID: 15319617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Receipt of glucocorticoid monotherapy among Medicare beneficiaries with rheumatoid arthritis.
    Yazdany J; Tonner C; Schmajuk G; Lin GA; Trivedi AN
    Arthritis Care Res (Hoboken); 2014 Oct; 66(10):1447-55. PubMed ID: 25244314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.